To Determine Bioequivalence Under Fasting Conditions Completed Phase 2 Trials for Propranolol (DB00571)

IndicationStatusPhase
DBCOND0039998 (To Determine Bioequivalence Under Fasting Conditions)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00653120Bioavailability Study of Propranolol Under Fasting Conditions